SDH
ARKG icon

Sloy Dahl & Holst’s ARK Genomic Revolution ETF ARKG Stock Holding History

Sloy Dahl & Holst’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,044
Closed -$223K – 116
2025
Q3 		$223K Buy
+8,044
New +$203K 0.02% 105
2024
Q4 		– Sell
-12,465
Closed -$319K – 110
2024
Q3 		$319K Sell
12,465
-2,508
-17% -$63.9K 0.05% 73
2024
Q2 		$352K Buy
14,973
+1,723
+13% +$43.5K 0.07% 62
2024
Q1 		$381K Sell
13,250
-242
-2% -$7.28K 0.09% 58
2023
Q4 		$443K Buy
13,492
+2,079
+18% +$56.5K 0.09% 54
2023
Q3 		$318K Buy
11,413
+1,131
+11% +$37K 0.07% 61
2023
Q2 		$351K Sell
10,282
-215
-2% -$6.76K 0.06% 56
2023
Q1 		$316K Buy
10,497
+175
+2% +$5.42K 0.07% 48
2022
Q4 		$291K Sell
10,322
-1,349
-12% -$42.8K 0.1% 50
2022
Q3 		$384K Buy
11,671
+1,379
+13% +$50.6K 0.08% 49
2022
Q2 		$324K Buy
10,292
+1,761
+21% +$61.6K 0.08% 52
2022
Q1 		$392K Buy
8,531
+26
+0.3% +$1.24K 0.07% 48
2021
Q4 		$635K Hold
8,505
– – 0.14% 40
2021
Q3 		$635K Sell
8,505
-1,421,578
-99% -$119M 0.14% 40
2021
Q2 		$132M Buy
1,430,083
+70,915
+5% +$6.03M 17.79% 3
2021
Q1 		$121M Buy
+1,359,168
New +$135M 17.25% 3

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Sloy Dahl & Holst's ARKG Position: Q4 2025 in Review

Sloy Dahl & Holst sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2025, closing a stake of 8,044 shares — an estimated $223K sold.

Sloy Dahl & Holst first reported a position in ARKG in Q1 2021 and held it in 16 quarters. The position peaked at $132M in Q2 2021. 239 funds tracked by Wall St. Rank hold ARKG as of Q4 2025.

  • Sloy Dahl & Holst reported no remaining ARK Genomic Revolution ETF position as of Q4 2025 after selling out during the quarter.
  • Sloy Dahl & Holst sold 8,044 ARK Genomic Revolution ETF shares in Q4 2025, an estimated $223K.
  • Sloy Dahl & Holst first reported a position in ARK Genomic Revolution ETF in Q1 2021 and held it in 16 quarters.
  • Sloy Dahl & Holst's ARK Genomic Revolution ETF position peaked at $132M in Q2 2021.
  • 239 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2025.

Based on Sloy Dahl & Holst's 13F filing for Q4 2025, filed 4 Feb 2026.